⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13632296 | 1.00 | — | — | |
| SCHEMBL12259738 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1972662 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL26613851 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL1972660 | 0.98 | — | — | |
| SCHEMBL10511174 | 0.93 | — | — | |
| SCHEMBL28329879 | 0.91 | ALDH1A1 (0.35) | — | |
| Hydrochloric Acid SCHEMBL31578567 | 0.91 | DRD2 (0.33) | — | |
| Formic Acid SCHEMBL30610872 | 0.88 | SLC6A1 (0.38) | — | |
| SCHEMBL1937488 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119998275-A | KRAS inhibitors | 百时美施贵宝公司 | 2025-05-13 | — | — | CN | claimed |
| CN-117881397-A | Heterocyclic compounds and methods of use | 安进公司 | 2024-04-12 | — | — | CN | claimed |
| CN-115368382-A | KRAS G12D inhibitor and application thereof in medicines | 贝达药业股份有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-114650995-A | [1,4] oxazepine [2,3-C ] quinolinone derivatives as BCL6 inhibitors | 癌症研究技术有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-108707151-B | Pyrimido-pyridazinone compounds and uses thereof | 阿萨纳生物科技有限责任公司 | 2022-06-03 | — | — | CN | claimed |
| CN-109715612-A | SOMATOSTATIN MODULATORS AND USES THEREOF | 克林提克斯医药股份有限公司 | 2019-05-03 | — | — | CN | claimed |
| CN-109476645-A | New pyrimidine carboxamide as VANIN-1 enzyme inhibitor | 辉瑞大药厂 | 2019-03-15 | — | — | CN | claimed |
| CN-108707151-A | Pyrimido-pyridazinone compound and application thereof | 阿萨纳生物科技有限责任公司 | 2018-10-26 | — | — | CN | claimed |
| CN-103974955-B | Pyrimido-pyridazinone compounds and uses thereof | 阿萨纳生物科技有限责任公司 | 2018-06-19 | — | — | CN | claimed |
| CN-104662018-B | Substituted Heterobicyclic compounds, composition and its medical applications | 阿迪维纳斯治疗有限公司 | 2017-10-24 | — | — | CN | claimed |
| CN-103974955-A | Pyrimido-pyridazinone compounds and uses thereof | ENDO PHARMACEUTICALS INC | 2014-08-06 | — | — | CN | claimed |
| US-7348435-B2 | Process for producing cyanopiperidine | JUBILANT ORGANOSYS LIMITED (IN) | 2008-03-25 | — | — | US | claimed |
| US-20060084808-A1 | Process for producing cyanopiperidine | JUBILANT ORGANOSYS LIMITED (IN) | 2006-04-20 | — | — | US | claimed |
| CN-121591671-A | Preparation method of nitrogen heterocyclic difluoro sulfonyl imide salt derivative | 张家港市国泰华荣化工新材料有限公司 | 2026-03-03 | — | — | CN | disclosed |
| US-12545675-B2 | Anti-wolbachia pyrido[2,3-d]pyrimidine compounds | LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) | 2026-02-10 | — | — | US | disclosed |
| US-12528826-B2 | [1,4]oxazepino[2,3-c]quinolinone derivatives as BCL6 inhibitors | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2026-01-20 | — | — | US | disclosed |
| WO-1996032943-A1 | 3-SUBSTITUTED PIPERIDINES PROMOTE RELEASE OF GROWTH HORMONE | MERCK & CO., INC. (US) | 1996-10-24 | — | — | WO | disclosed |
| US-5559128-A | FOOD ANIMALS; MEDICAL DIAGNOSIS | MERCK & CO., INC. (US) | 1996-09-24 | — | — | US | disclosed |
| US-5128348-A | BICYCLO(3.1.0)HEXANE AMINES AND BICYCLO(4.1.0)-HEPTANE AMINES AS AGRICULTURAL FUNGICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-07-07 | — | — | US | disclosed |
| EP-0252876-A1 | Hydrogenated 1-phenoxyalkylpyridine-3-carboxylic-acid compounds | CIBA-GEIGY AG (CH) | 1988-01-13 | — | — | EP | disclosed |